A Study of BGM-2121 in Patients With Advanced Solid Tumors
NCT07346846 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 35
Last updated 2026-04-21
Summary
This study is to explore the safety, tolerability, pharmacokinetics, and preliminary efficacy of BGM-2121 in adult patients with advanced solid tumors.
Conditions
Interventions
- DRUG
-
BGM-2121
BGM-2121 treatment
Sponsors & Collaborators
-
BioGate Precision Medicine Corp.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-03-10
- Primary Completion
- 2027-11-30
- Completion
- 2028-12-31
- FDA Drug
- Yes
Countries
- Taiwan
Study Locations
More Related Trials
-
Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors
NCT06598800 ·Status: RECRUITING ·Phase: PHASE1
-
The Study of BGB-283 in Chinese Subjects With Local Advanced or Metastatic Malignant Solid Tumor
NCT03641586 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Pharmacokinetics and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab in Participants With Solid Tumors in Chinese Participants
NCT05644626 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study of ZGGS34 in Participants With Advanced Solid Tumors
NCT07258121 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors
NCT07279428 ·Status: RECRUITING ·Phase: PHASE1
-
Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors
NCT06834542 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
GT201 Injection For The Treatment Of Advanced Solid Tumors
NCT06144671 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors
NCT07181720 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors.
NCT05877924 ·Status: RECRUITING ·Phase: PHASE1
-
First-in-human Study of 7MW4911 in Patients With Advanced Solid Tumors
NCT07265622 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of DEG6498 in Participants With Solid Tumors
NCT07244835 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of BL-M05D1 in Patients With Locally Advanced or Metastatic Solid Tumors
NCT06349811 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT07050459 ·Status: RECRUITING ·Phase: PHASE1
-
A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T
NCT05468190 ·Status: UNKNOWN ·Phase: PHASE1
-
BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors
NCT05935098 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
NCT06818643 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of Microwave Ablation Combined With Immunotherapy ± Anti-angiogenic Drugs in the Treatment of Solid Tumors
NCT06537505 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of PM1015 in Patients With Advanced Solid Tumors
NCT05950815 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors
NCT05170958 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Evaluation of ICP-B794 in Patients With Advanced Solid Tumors
NCT07136558 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors
NCT06500052 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors
NCT06475300 ·Status: RECRUITING ·Phase: PHASE2
-
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
NCT05420545 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Solid Tumors
NCT05729399 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Study of BL-M08D1 in Patients With Locally Advanced or Metastatic Solid Tumors
NCT06718621 ·Status: RECRUITING ·Phase: PHASE1